Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 481 to 485 of 485 entries
Sorted by: Best Match Show Resources per page
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.

The New England journal of medicine

Kalinsky K, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF, Lin NU, Perez EA, Goldstein LJ, Chia SKL, Dhesy-Thind S, Rastogi P, Alba E, Delaloge S, Martin M, Kelly CM, Ruiz-Borrego M, Gil-Gil M, Arce-Salinas CH, Brain EGC, Lee ES, Pierga JY, Bermejo B, Ramos-Vazquez M, Jung KH, Ferrero JM, Schott AF, Shak S, Sharma P, Lew DL, Miao J, Tripathy D, Pusztai L, Hortobagyi GN.
PMID: 34914339
N Engl J Med. 2021 Dec 16;385(25):2336-2347. doi: 10.1056/NEJMoa2108873. Epub 2021 Dec 01.

BACKGROUND: The recurrence score based on the 21-gene breast-cancer assay has been clinically useful in predicting a chemotherapy benefit in hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, axillary lymph-node-negative breast cancer. In women with positive lymph-node disease, the...

Cite
Kalinsky K, Barlow WE, Gralow JR, et al. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer. N Engl J Med. 2021;385(25):2336-2347doi: 10.1056/NEJMoa2108873.
Kalinsky, K., Barlow, W. E., Gralow, J. R., Meric-Bernstam, F., Albain, K. S., Hayes, D. F., Lin, N. U., Perez, E. A., Goldstein, L. J., Chia, S. K. L., Dhesy-Thind, S., Rastogi, P., Alba, E., Delaloge, S., Martin, M., Kelly, C. M., Ruiz-Borrego, M., Gil-Gil, M., Arce-Salinas, C. H., Brain, E. G. C., Lee, E. S., Pierga, J. Y., Bermejo, B., Ramos-Vazquez, M., Jung, K. H., Ferrero, J. M., Schott, A. F., Shak, S., Sharma, P., Lew, D. L., Miao, J., Tripathy, D., Pusztai, L., & Hortobagyi, G. N. (2021). 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer. The New England journal of medicine, 385(25), 2336-2347. https://doi.org/10.1056/NEJMoa2108873
Kalinsky, Kevin, et al. "21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer." The New England journal of medicine vol. 385,25 (2021): 2336-2347. doi: https://doi.org/10.1056/NEJMoa2108873
Kalinsky K, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF, Lin NU, Perez EA, Goldstein LJ, Chia SKL, Dhesy-Thind S, Rastogi P, Alba E, Delaloge S, Martin M, Kelly CM, Ruiz-Borrego M, Gil-Gil M, Arce-Salinas CH, Brain EGC, Lee ES, Pierga JY, Bermejo B, Ramos-Vazquez M, Jung KH, Ferrero JM, Schott AF, Shak S, Sharma P, Lew DL, Miao J, Tripathy D, Pusztai L, Hortobagyi GN. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer. N Engl J Med. 2021 Dec 16;385(25):2336-2347. doi: 10.1056/NEJMoa2108873. Epub 2021 Dec 01. PMID: 34914339.
Copy Download .nbib Format: NLM
Polyethylene glycol-coated collagen patch (hemopatch.

World journal of urology

Staehler M, Rodler S, Schott M, Casuscelli J, Stief C, Spek A, Schlenker B.
PMID: 34480235
World J Urol. 2021 Sep 03; doi: 10.1007/s00345-021-03827-x. Epub 2021 Sep 03.

PURPOSE: To describe the results of a polyethylene glycol-coated collagen patch, HemopatchMETHODS: Out of a single surgeon cohort of n = 565 patients undergoing conventional open PN (CPN) between 01/2015 and 12/2017 at the University of Munich a consecutive...

Cite
Staehler M, Rodler S, Schott M, et al. Polyethylene glycol-coated collagen patch (hemopatch. World J Urol. 2021;doi: 10.1007/s00345-021-03827-x.
Staehler, M., Rodler, S., Schott, M., Casuscelli, J., Stief, C., Spek, A., & Schlenker, B. (2021). Polyethylene glycol-coated collagen patch (hemopatch. World journal of urology, . https://doi.org/10.1007/s00345-021-03827-x
Staehler, Michael, et al. "Polyethylene glycol-coated collagen patch (hemopatch." World journal of urology vol. (2021). doi: https://doi.org/10.1007/s00345-021-03827-x
Staehler M, Rodler S, Schott M, Casuscelli J, Stief C, Spek A, Schlenker B. Polyethylene glycol-coated collagen patch (hemopatch. World J Urol. 2021 Sep 03; doi: 10.1007/s00345-021-03827-x. Epub 2021 Sep 03. PMID: 34480235.
Copy Download .nbib Format: NLM
DZIP1 regulates mammalian cardiac valve development through a Cby1-β-catenin mechanism.

Developmental dynamics : an official publication of the American Association of Anatomists

Guo L, Beck T, Fulmer D, Ramos-Ortiz S, Glover J, Wang C, Moore K, Gensemer C, Morningstar J, Moore R, Schott JJ, Le Tourneau T, Koren N, Norris RA.
PMID: 33811421
Dev Dyn. 2021 Oct;250(10):1432-1449. doi: 10.1002/dvdy.342. Epub 2021 Apr 09.

BACKGROUND: Mitral valve prolapse (MVP) is a common and progressive cardiovascular disease with developmental origins. How developmental errors contribute to disease pathogenesis are not well understood.RESULTS: A multimeric complex was identified that consists of the MVP gene Dzip1, Cby1,...

Cite
Guo L, Beck T, Fulmer D, et al. DZIP1 regulates mammalian cardiac valve development through a Cby1-β-catenin mechanism. Dev Dyn. 2021;250(10):1432-1449doi: 10.1002/dvdy.342.
Guo, L., Beck, T., Fulmer, D., Ramos-Ortiz, S., Glover, J., Wang, C., Moore, K., Gensemer, C., Morningstar, J., Moore, R., Schott, J. J., Le Tourneau, T., Koren, N., & Norris, R. A. (2021). DZIP1 regulates mammalian cardiac valve development through a Cby1-β-catenin mechanism. Developmental dynamics : an official publication of the American Association of Anatomists, 250(10), 1432-1449. https://doi.org/10.1002/dvdy.342
Guo, Lilong, et al. "DZIP1 regulates mammalian cardiac valve development through a Cby1-β-catenin mechanism." Developmental dynamics : an official publication of the American Association of Anatomists vol. 250,10 (2021): 1432-1449. doi: https://doi.org/10.1002/dvdy.342
Guo L, Beck T, Fulmer D, Ramos-Ortiz S, Glover J, Wang C, Moore K, Gensemer C, Morningstar J, Moore R, Schott JJ, Le Tourneau T, Koren N, Norris RA. DZIP1 regulates mammalian cardiac valve development through a Cby1-β-catenin mechanism. Dev Dyn. 2021 Oct;250(10):1432-1449. doi: 10.1002/dvdy.342. Epub 2021 Apr 09. PMID: 33811421; PMCID: PMC8518365.
Copy Download .nbib Format: NLM
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.

The New England journal of medicine

Kalinsky K, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF, Lin NU, Perez EA, Goldstein LJ, Chia SKL, Dhesy-Thind S, Rastogi P, Alba E, Delaloge S, Martin M, Kelly CM, Ruiz-Borrego M, Gil-Gil M, Arce-Salinas CH, Brain EGC, Lee ES, Pierga JY, Bermejo B, Ramos-Vazquez M, Jung KH, Ferrero JM, Schott AF, Shak S, Sharma P, Lew DL, Miao J, Tripathy D, Pusztai L, Hortobagyi GN.
PMID: 34914339
N Engl J Med. 2021 Dec 16;385(25):2336-2347. doi: 10.1056/NEJMoa2108873. Epub 2021 Dec 01.

BACKGROUND: The recurrence score based on the 21-gene breast-cancer assay has been clinically useful in predicting a chemotherapy benefit in hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, axillary lymph-node-negative breast cancer. In women with positive lymph-node disease, the...

Cite
Kalinsky K, Barlow WE, Gralow JR, et al. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer. N Engl J Med. 2021;385(25):2336-2347doi: 10.1056/NEJMoa2108873.
Kalinsky, K., Barlow, W. E., Gralow, J. R., Meric-Bernstam, F., Albain, K. S., Hayes, D. F., Lin, N. U., Perez, E. A., Goldstein, L. J., Chia, S. K. L., Dhesy-Thind, S., Rastogi, P., Alba, E., Delaloge, S., Martin, M., Kelly, C. M., Ruiz-Borrego, M., Gil-Gil, M., Arce-Salinas, C. H., Brain, E. G. C., Lee, E. S., Pierga, J. Y., Bermejo, B., Ramos-Vazquez, M., Jung, K. H., Ferrero, J. M., Schott, A. F., Shak, S., Sharma, P., Lew, D. L., Miao, J., Tripathy, D., Pusztai, L., & Hortobagyi, G. N. (2021). 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer. The New England journal of medicine, 385(25), 2336-2347. https://doi.org/10.1056/NEJMoa2108873
Kalinsky, Kevin, et al. "21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer." The New England journal of medicine vol. 385,25 (2021): 2336-2347. doi: https://doi.org/10.1056/NEJMoa2108873
Kalinsky K, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF, Lin NU, Perez EA, Goldstein LJ, Chia SKL, Dhesy-Thind S, Rastogi P, Alba E, Delaloge S, Martin M, Kelly CM, Ruiz-Borrego M, Gil-Gil M, Arce-Salinas CH, Brain EGC, Lee ES, Pierga JY, Bermejo B, Ramos-Vazquez M, Jung KH, Ferrero JM, Schott AF, Shak S, Sharma P, Lew DL, Miao J, Tripathy D, Pusztai L, Hortobagyi GN. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer. N Engl J Med. 2021 Dec 16;385(25):2336-2347. doi: 10.1056/NEJMoa2108873. Epub 2021 Dec 01. PMID: 34914339.
Copy Download .nbib Format: NLM
Sacred images of the West and alleviation of pain: belief, placebo and harnessing hope.

Journal of the Royal Society of Medicine

Schott GD.
PMID: 34786997
J R Soc Med. 2021 Dec;114(12):552-555. doi: 10.1177/01410768211056315. Epub 2021 Nov 17.

No abstract available.

Cite
Schott GD. Sacred images of the West and alleviation of pain: belief, placebo and harnessing hope. J R Soc Med. 2021;114(12):552-555doi: 10.1177/01410768211056315.
Schott, G. D. (2021). Sacred images of the West and alleviation of pain: belief, placebo and harnessing hope. Journal of the Royal Society of Medicine, 114(12), 552-555. https://doi.org/10.1177/01410768211056315
Schott, G D. "Sacred images of the West and alleviation of pain: belief, placebo and harnessing hope." Journal of the Royal Society of Medicine vol. 114,12 (2021): 552-555. doi: https://doi.org/10.1177/01410768211056315
Schott GD. Sacred images of the West and alleviation of pain: belief, placebo and harnessing hope. J R Soc Med. 2021 Dec;114(12):552-555. doi: 10.1177/01410768211056315. Epub 2021 Nov 17. PMID: 34786997; PMCID: PMC8722779.
Copy Download .nbib Format: NLM
Showing 481 to 485 of 485 entries